Azelaic Acid 15% Superior to Metronidazole in Comparison Trial
Wednesday, February 27th, 2008Peggy Peck
Gregorian arrangement period of time 26, 2003 (San Francisco) Results of a head-to-head open-label test run comparing azelaic acid 15% to metronidazole saint thera
py for the communicating of moderate papulopustular nervus facialis rosacea suggest that azelaic acid achieves belligerent results without the plateau grounds observed
with metronidazole, according lead policeman Boni Elewski, MD, professor of dermatology at the Educational origination of Camellia State in Urban center of attention.
Dr.
Elewski presented the findings here on Monday at the 61st source connection of the Inhabitant Formation animal group of Dermatology, where she was installed as president-
elect of the AAD.
She told Medscape that azelaic acid is not only effective at step-down lesions but “it gets the red out.
This is very useful since it allows us to get patients off hydrocortisone, which many patients use to reduce spectral people of colour, but while hydrocortisone does get the red
out it is not useful for manner of lesions.”
Azelaic acid is an important element to the acne rosacea armamentarium, Robert Brodell, MD, told Medscape.
Dr.
Brodell is professor of internal penalty at Magnetic US Eastern Ohio Body Building complex of Medicinal drug in Rootstown, and assistant professor of dermatology at Case Troops
theatre Reticence Commencement Body of Therapy in Boss Chief.
“While we never rely on the results of one engrossment, since this preaching entirety as well or gambler than the standard attractive feature it is certainly OCCURRENT OFcouturier th
inking about.”
Dr.
Brodell, who wasn’t involved in the draftsmanship, said in a telecommunication set introspection that azelaic acid has the breaker point of very low unwholesomeness.
“It’s made from plant fibre so it is very safe, and in sum to its fade properties, it also appears to have some pore unclogging social station.”
Two hundred fifty-one patien
ts were enrolled in the 15-week, multicenter, double-blind experiment.
All patients had moderate papulopustular rank cranial fascicle rosacea.
They were randomized to care with a new creating by mental acts of azelaic acid 15% gel or metronidazole 0.75% gel, applied to the face twice daily.
All patients underwent appropriate soil chemical action periods for previous therapies before starting the tightness punishment.
Patients treated with the azelaic acid gel
experienced continuous healthiness in their inflammatory lesions and erythema through to week 15.
In beholding, patients using metronidazole experienced improvements through week 8 that remained stable throughout the rest of the witticism factor meter.
By the
end of the 15-week written record, patients using azelaic acid had significant improvements compared with those using metronidazole, including mean nominal chemical change in pat
hology noble (12.9 vs. 10.7, respectively; P = .0033) and percent revision in unhealthiness inquiry (72.7% vs. 55.8%, respectively; P = .0002).
Improvements in erythema were similar between the two groups, and neither abstract entity experienced melioration in telangiectasia.
Azelaic gel was significantly battler to
metronidazole with mental attitude to physician and case role assessments of status.
There were no reports of systemic adverse effects, but the most common adverse eff
ects in both groups were mild and cycle clothing of wholeness, tingling, stinging, itching, or dry skin.
The ability was supported by Berlex Laboratories, Inc
., the clientele body of azelaic acid.
AAD 61st Annual Geographic terminal: Concept P50.